Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”It was a privilege to speak at the West Bengal Hemophilia Conclave 2026, held on 4 July 2026 at Taj Taal Kutir, Kolkata.
I had the opportunity to deliver a lecture on ‘Cost-effectiveness and Health Technology Assessment (HTA) in Hemophilia Therapies: The ICMR Perspective,’ highlighting the role of evidence-based evaluation in improving access to sustainable hemophilia care in India.
My sincere thanks to the Program Director, Prof. (Dr.) Maitreyee Bhattacharyya, for the kind invitation. It was an honour to have the session chaired by the eminent Dr. Prakas Kumar Mandal and Dr. Madhumita Nandi.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 13:39Abuzar Ghaffari: A Proud ISBT Congress Milestone
-
Jul 7, 2026, 13:24Christoph B. Olivier: New DGK Consensus Recommendations on Switching Antiplatelet Therapies
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year